{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:49:32Z","timestamp":1774435772950,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Tufts Institute for Innovation, the National Institutes of Health","award":["UL1TR001064"],"award-info":[{"award-number":["UL1TR001064"]}]},{"name":"Tufts Institute for Innovation, the National Institutes of Health","award":["KL2TR001063"],"award-info":[{"award-number":["KL2TR001063"]}]},{"name":"Lifespan\/Tufts\/Brown Center for AIDS Research","award":["P30 AI042853"],"award-info":[{"award-number":["P30 AI042853"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.drugalcdep.2018.06.013","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T19:24:08Z","timestamp":1532114648000},"page":"246-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"special_numbering":"C","title":["\u2018Hep C\u2019s like the common cold\u2019: understanding barriers along the HCV care continuum among young people who inject drugs"],"prefix":"10.1016","volume":"190","author":[{"given":"Margie R.","family":"Skeer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keren","family":"Ladin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay E.","family":"Wilkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Landy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Stopka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2018.06.013_bib0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.drugpo.2003.10.009","article-title":"Beyond prevention? Injecting drug user narratives about hepatitis C","volume":"15","author":"Davis","year":"2004","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2018.06.013_bib0010","series-title":"A Behavioral Model of Families\u2019 Use of Health Services","author":"Andersen","year":"1968"},{"key":"10.1016\/j.drugalcdep.2018.06.013_bib0015","article-title":"Societal and individual determinants of medical care utilization in the United States","volume":"83","author":"Anderson","year":"2005","journal-title":"Milbank Q."},{"key":"10.1016\/j.drugalcdep.2018.06.013_bib0020","series-title":"State Lowers Requirements for Mass Health Patients to Get Hepatitis C Drugs","author":"Bartlett","year":"2016"},{"key":"10.1016\/j.drugalcdep.2018.06.013_bib0025","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.drugalcdep.2015.06.007","article-title":"\"Hepatitis C treatment turned me around:\u201d Psychological and behavioral transformation related to hepatitis C treatment","volume":"153","author":"Batchelder","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.06.013_bib0030","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/1363459314555237","article-title":"Resolute efforts to cure hepatitis C: understanding patients\u2019 reasons for completing antiviral treatment","volume":"19","author":"Clark","year":"2015","journal-title":"Health"},{"key":"10.1016\/j.drugalcdep.2018.06.013_bib0035","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/hep.28227","article-title":"Hepatitis C treatment as prevention of viral transmission and liver\u2010related morbidity in persons who inject drugs","volume":"63","author":"Cousien","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.drugalcdep.2018.06.013_bib0040","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.drugpo.2004.08.005","article-title":"Managing seen and unseen blood associated with drug injecting: Implications for theorising harm reduction for viral risk","volume":"15","author":"Davis","year":"2004","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2018.06.013_bib0045","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.socscimed.2004.02.021","article-title":"Preventing hepatitis C: \u2018Common sense\u2019, \u2018the bug\u2019 and other perspectives from the risk narratives of people who inject drugs","volume":"59","author":"Davis","year":"2004","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.drugalcdep.2018.06.013_bib0050","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/ajg.2015.31","article-title":"Lack of health insurance limits the benefits of hepatitis C virus screening: insights from the national health and nutrition examination hepatitis C follow-up study","volume":"110","author":"Ditah","year":"2015","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.drugalcdep.2018.06.013_bib0055","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.antiviral.2014.01.002","article-title":"Can hepatitis C virus infection be eradicated in people who inject drugs?","volume":"104","author":"Grebely","year":"2014","journal-title":"Antiviral Res."},{"key":"10.1016\/j.drugalcdep.2018.06.013_bib0060","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/cid\/cit377","article-title":"Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirements","volume":"57","author":"Grebely","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2018.06.013_bib0065","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1477-7517-10-7","article-title":"Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors","volume":"10","author":"Harris","year":"2013","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.drugalcdep.2018.06.013_bib0070","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1056\/NEJMoa1214854","article-title":"Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options","volume":"368","author":"Jacobson","year":"2013","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2018.06.013_bib0075","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/hep.21470","article-title":"Hepatitis C virus eradication in intravenous drug users maintained with subcutaneous naltrexone implants","volume":"45","author":"Jeffrey","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.drugalcdep.2018.06.013_bib0080","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12981-016-0120-0","article-title":"The HIV treatment cascade and care continuum: updates, goals, and recommendations for the future","volume":"13","author":"Kay","year":"2016","journal-title":"AIDS Res. Ther."},{"key":"10.1016\/j.drugalcdep.2018.06.013_bib0085","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.socscimed.2008.10.011","article-title":"A meta-analysis of the hepatitis C virus distribution in diverse racial\/ethnic drug injector groups","volume":"68","author":"Lelutiu-Weinberger","year":"2009","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.drugalcdep.2018.06.013_bib0090","series-title":"Clinical Advisory: Routine Screening for Hepatitis C","author":"Massachusetts Department of Public Health (MDPH)","year":"2014"},{"key":"10.1016\/j.drugalcdep.2018.06.013_bib0095","series-title":"Qualitative Data Analysis","author":"Miles","year":"1994"},{"key":"10.1016\/j.drugalcdep.2018.06.013_bib0100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2524.2007.00739.x","article-title":"Barriers to accessing generic health and social care services: a qualitative study of injecting drug users","volume":"16","author":"Neale","year":"2008","journal-title":"Health Soc. Care Commun."},{"key":"10.1016\/j.drugalcdep.2018.06.013_bib0105","series-title":"Hepatitis C: the State of Medicaid Access Preliminary Findings: National Summary Report","author":"National Viral Hepatitis Roundtable (NVHR) and the Center for Health Law and Policy Innovation","year":"2016"},{"issue":"Suppl. 2","key":"10.1016\/j.drugalcdep.2018.06.013_bib0110","first-page":"S104","article-title":"Psychoeducation improves hepatitis C virus treatment during opioid substitution therapy: a controlled, prospective multicenter trial","volume":"57","author":"Reimer","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2018.06.013_bib0115","series-title":"The Coding Manual for Qualitative Researchers","author":"Salda\u00f1a","year":"2013"},{"key":"10.1016\/j.drugalcdep.2018.06.013_bib0120","series-title":"Perceptions of Health and Illness","first-page":"103","article-title":"Measurement of illness perceptions in patients with chronic somatic illnesses: a review","author":"Scharloo","year":"2013"},{"key":"10.1016\/j.drugalcdep.2018.06.013_bib0125","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1001\/jama.280.6.567","article-title":"Adherence and antiretroviral therapy in injection drug users","author":"Sherer","year":"1998","journal-title":"JAMA 280"},{"key":"10.1016\/j.drugalcdep.2018.06.013_bib0130","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/cid\/ciu643","article-title":"Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006\u20132012","volume":"59","author":"Suryaprasad","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2018.06.013_bib0135","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/cid\/ciu697","article-title":"Infrequent development of resistance in genotype 1\u20136 hepatitis C virus-infected subjects treated with sofosbuvir in phase 2 and 3 clinical trials","volume":"59","author":"Svarovskaia","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2018.06.013_bib0140","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1465-3362.2012.00468.x","article-title":"Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs","volume":"31","author":"Treloar","year":"2012","journal-title":"Drug Alcohol Rev."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618303740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618303740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T10:26:16Z","timestamp":1563791176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871618303740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":28,"alternative-id":["S0376871618303740"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.06.013","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u2018Hep C\u2019s like the common cold\u2019: understanding barriers along the HCV care continuum among young people who inject drugs","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}